Alzheimer Disease Prodromal
📧 Sign up to get email alerts when something new happens for Alzheimer Disease Prodromal.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease [Phase 2, Phase 3]
AgeneBio's AGB101 in mild cognitive impairment due to Alzheimer's disease has completed Phase 2/Phase 3 with results posted on 2024-05-17.